The DOI matches its Crossref record; 284 of the 284 references it cites were found in a registry or an index.
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–284 of 284
Quality of life in a cohort of high-dose benzodiazepine dependent patients
Lugoboni, F., Mirijello, A., Faccini, M., Casari, R., Cossari, A., Musi, G., Bissoli, G. C., Quaglio, G., & Addolorato, G. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.06.020 · Cited by 79
Comai, S., Ochoa‐Sanchez, R., Domínguez-López, S., Bambico, F. R., & Gobbi, G. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu075 · Cited by 77
Self-citationThe Sleep-Promoting Action of Ramelteon (TAK-375) in Freely Moving Cats
Miyamoto, M., Nishikawa, H., Doken, Y., Hirai, K., Uchikawa, O., & Ohkawa, S. (2004) · SLEEP · doi:10.1093/sleep/27.7.1319 · Cited by 75
Tannenbaum, C., Diaby, V., Singh, D. K., Perreault, S., Luc, M., & Vasiliadis, H. (2015) · Drugs & Aging · doi:10.1007/s40266-015-0251-3 · Cited by 74
Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis
Liu, J., & Wang, L.-N. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.02987.x · Cited by 72
Gobbi, G., & Blier, P. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.032 · Cited by 72
Self-citationEndicott, J., Paulsson, B., Gustafsson, U., Schiöler, H., & Hassan, M. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.06.019 · Cited by 71
Modification of serotonin neuron properties in mice lacking 5-HT1A receptors
Richer, M., Hen, R., & Blier, P. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01607-7 · Cited by 69
Olanzapine in the treatment‐resistant, combat‐related PTSD – a series of case reports
Jakovljević, M., Šagud, M., & Mihaljević-Peleš, A. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00065.x · Cited by 69
Progressive disruption of the circadian rhythm of melatonin in fatal familial insomnia
Portaluppi, F., Cortelli, P., Avoni, P., Vergnani, L., Maltoni, P., Pavani, A., Sforza, E. A., Uberti, E. C. D., Gambetti, P., & Lugaresi, E. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.5.8175963 · Cited by 69
Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys
Yukuhiro, N., Kimura, H., Nishikawa, H., Ohkawa, S., Yoshikubo, S.-I., & Miyamoto, M. (2004) · Brain Research · doi:10.1016/j.brainres.2004.08.035 · Cited by 68
Effect of Ramelteon on Middle-of-the-Night Balance in Older Adults with Chronic Insomnia
Zammit, G. K., Wang‐Weigand, S., Rosenthal, M. H., & Peng, X. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27390 · Cited by 68
Exploratory Polysomnographic Evaluation of Pregabalin on Sleep Disturbance in Patients with Epilepsy
de Haas, S., Otte, A., de Weerd, A., van Erp, G., Cohen, A. F., & van Gerven, J. (2007) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.26911 · Cited by 67
Berridge, C. W., & España, R. A. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00215-3 · Cited by 66
McElroy, S. L., Winstanley, E. L., Martens, B. E., Patel, N. C., Mori, N. N., Moeller, D., McCoy, J. J., & Keck, P. E. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e3283400d35 · Cited by 66
Greenblatt, D. J., Harmatz, J. S., & Karim, A. (2007) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006298602 · Cited by 65
Bazil, C. W., Dave, J., Cole, J., Stalvey, J., & Drake, E. (2012) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.02.005 · Cited by 64
Quetiapine Improves Sleep Disturbances in Combat Veterans With PTSD
Robert, S., Hamner, M. B., Köse, S., Ulmer, H. G., Deitsch, S. E., & Lorberbaum, J. P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169624.37819.60 · Cited by 62
Gooneratne, N. S., Gehrman, P., Gurubhagavatula, I., Al-Shehabi, E., Marie, E., & Schwab, R. J. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27991 · Cited by 60
Hartmann, E. L., & Cravens, J. (1973) · Psychopharmacology · doi:10.1007/bf00429087 · Cited by 59
Agomelatine: a novel antidepressant.
Sansone, R. A., & Sansone, L. A. (2011) · Europe PMC (PubMed Central) · Cited by 58
Tasimelteon: A selective and unique receptor binding profile
Lavedan, C. N., Forsberg, M. A., & Gentile, A. J. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.12.004 · Cited by 58
Effects of pregabalin on sleep in generalized anxiety disorder
Holsboer‐Trachsler, E., & Prieto, R. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000922 · Cited by 57
Quetiapine for primary insomnia: a double blind, randomized controlled trial.
Tassniyom, K., Paholpak, S., Tassniyom, S., & Kiewyoo, J. (2010) · PubMed · Cited by 57
Ware, J. C., Rose, F. V., & McBrayer, R. H. (1994) · Sleep · doi:10.1093/sleep/17.6.544 · Cited by 56
Optogenetic deconstruction of sleep-wake circuitry in the brain
Adamantidis, A., Carter, M. C. D., & de Lecea, L. (2010) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.031.2009 · Cited by 55
Stein, M. D., Kurth, M. E., Sharkey, K. M., Anderson, B. J., Corso, R. P., & Millman, R. P. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.06.026 · Cited by 54
Zisapel, N., Lemoine, Garfinkel, D., Laudon, M., & Nir (2011) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s23036 · Cited by 54
Pregabalin Enhances Nonrapid Eye Movement Sleep
Kubota, T., Fang, J., Meltzer, L. T., & Krueger, J. M. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29233-8 · Cited by 53
Montgomery, S., Herman, B. K., Schweizer, E. E., & Mandel, F. S. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32832dceb9 · Cited by 53
Gondard, E., Anaclet, C., Akaoka, H., Guo, R., Zhang, M., Buda, C., Franco, P., Kotani, H., & Lin, J. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.266 · Cited by 53
Kluge, M., Schacht, A., Himmerich, H., Rummel‐Kluge, C., Wehmeier, P. M., Dalal, M. A., Hinze‐Selch, D., Kraus, T., Dittmann, R., Pollmächer, T., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.11.009 · Cited by 52
Odagaki, Y., Toyoshima, R., & Yamauchi, T. (2005) · Journal of Psychopharmacology · doi:10.1177/0269881105051526 · Cited by 51
Acute sleep‐promoting action of the melatonin agonist, ramelteon, in the rat
Fisher, S. P., Davidson, K., Kulla, A., & Sugden, D. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00565.x · Cited by 49
Hinz, R., Bhagwagar, Z., Cowen, P., Cunningham, V., & Grasby, P. (2007) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/sj.jcbfm.9600323 · Cited by 49
The use of antidepressants in clinical practice: focus on agomelatine
McAllister-Williams, H., Baldwin, D. S., Haddad, P. M., & Bazire, S. (2010) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1094 · Cited by 49
Effects of trazodone hydrochloride and imipramine on polysomnography in healthy subjects
YAMADERA, H., NAKAMURA, S., SUZUKI, H., & ENDO, S. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.1998.00403.x · Cited by 48
Descamps, A., Rousset, C., Millan, M. J., Spedding, M., Delagrange, P., & Cespuglio, R. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1519-2 · Cited by 48
Night Locomotor Activity and Quality of Sleep in Quetiapine-treated Patients With Depression
Todder, D., Caliskan, S., & Baune, B. T. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000239798.59943.77 · Cited by 47
Rodriguez, J. J., Noristani, H. N., Hoover, W. B., Linley, S. B., & Vertes, R. P. (2011) · Synapse · doi:10.1002/syn.20920 · Cited by 46
Distinct effects of IPSU and suvorexant on mouse sleep architecture
Hoyer, D., Dürst, T., Fendt, M., Jacobson, L. H., Betschart, C., Hintermann, S., Behnke, D., Cotesta, S., Laue, G., Ofner, S., et al. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00235 · Cited by 46
Davis, R. E., Vanover, K. E., Zhou, Y., Brašić, J. R., Guevara, M. C., Bisuna, B., Ye, W., Raymont, V., Willis, W. D., Kumar, A., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3922-1 · Cited by 46
van Dyck, C. H., Tan, P., Baldwin, R. M., Amici, L. A., Garg, P., Ng, C. K., Soufer, R., Charney, D. S., & Innis, R. B. (2000) · PubMed · Cited by 46
Evaluation of subjective efficacy and safety of ramelteon in Japanese subjects with chronic insomnia
Uchiyama, M., Hamamura, M., Kuwano, T., Nishiyama, H., Nagata, H., & Uchimura, N. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2010.08.010 · Cited by 45
Viola, A., BRANDENBERGER, G., Toussaint, M., Bouhours, P., Macher, J. P., & Luthringer, R. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00014-7 · Cited by 43
Quetiapine augmentation in treatment-resistant depression: a naturalistic study
Šagud, M., Mihaljević-Peleš, A., Mück‐Šeler, D., Jakovljević, M., & Pivac, N. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0452-x · Cited by 42
Tasimelteon: A Melatonin Receptor Agonist for Non-24-Hour Sleep-Wake Disorder
Johnsa, J. D., & Neville, M. W. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014550476 · Cited by 42
Garakani, A., Martinez, J. M., Marcus, S. M., Weaver, J. C., Rickels, K., D, M. F. M., & Hirschowitz, J. (2008) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328301a74c · Cited by 41
Takemura, Y., Yamashita, A., Horiuchi, H., Furuya, M., Yanase, M., Niikura, K., Imai, S., Hatakeyama, N., Kinoshita, H., Tsukiyama, Y., et al. (2010) · Synapse · doi:10.1002/syn.20898 · Cited by 40
Sleep-waking discharge profiles of median preoptic and surrounding neurons in mice
Sakai, K. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.010 · Cited by 39
Effect of alpha-adrenoceptor blockade on sleep and wakefulness in the rat
Mäkelä, J. P., & Hilakivi, I. T. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90566-6 · Cited by 39
Blakley, G. G., Pohorecky, L. A., & Benjamin, D. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1597-5 · Cited by 37
Liu, Y., Yin, D., Chen, L., Qu, W., Chen, C., Laudon, M., Cheng, N., Urade, Y., & Huang, Z. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3530-5 · Cited by 37
Rosenberg, R. P., Hull, S. G., Lankford, D. A., Mayleben, D. W., Seiden, D., Furey, S. A., Jayawardena, S., & Roth, T. G. (2014) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.4108 · Cited by 36
The effects of trazodone on sleep disturbances induced by brofaromine
Haffmans, P. M. J., & Vos, M. S. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)80736-6 · Cited by 36
Efficacy and safety of doxepin 6 mg in a model of transient insomnia
Roth, T. G., Durrence, H. H., Jochelson, P., Peterson, G., Ludington, E. A., Rogowski, R., Scharf, M. B., & Lankford, A. (2010) · Sleep Medicine · doi:10.1016/j.sleep.2010.07.006 · Cited by 36
Ochoa‐Sanchez, R., Comai, S., Spadoni, G., Bedini, A., Tarzia, G., & Gobbi, G. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.069 · Cited by 34
Self-citationRivara, S., Vacondio, F., Fioni, A., Silva, C., Carmi, C., Mor, M., Lucini, V., Pannacci, M., Caronno, A., Scaglione, F., et al. (2009) · ChemMedChem · doi:10.1002/cmdc.200900240 · Cited by 34
Self-citationKohsaka, M., Kanemura, T., Taniguchi, M., Kuwahara, H., Mikami, A., Kamikawa, K., Uno, H., Ogawa, A., Murasaki, M., & Sugita, Y. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.11.128 · Cited by 34
Agomelatine: The Novel Antidepressant
Sup, W. Y., 왕희령, & Bahk, W. (2014) · 대한정신약물학회지 · Cited by 34
Management of insomnia: treatments and mechanisms
Wilson, S. J., & Nutt, D. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.036301 · Cited by 33
Utilization, Spending, and Price Trends for Benzodiazepines in the US Medicaid Program: 1991-2009
Gorevski, E., Bian, B., Kelton, C. M. L., Martin-Boone, J. E., & Guo, J. J. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q618 · Cited by 33
Sleep Quality and Architecture in Quetiapine, Risperidone, or Never-Treated Schizophrenia Patients
Keshavan, M. S., Prasad, K. M. R., Montrose, D. M., Miewald, J. M., & Kupfer, D. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31815a884d · Cited by 32
Dolev, Z. (2011) · Archives of Women s Mental Health · doi:10.1007/s00737-011-0205-7 · Cited by 30
Antinociceptive and hypnotic activities of pregabalin in a neuropathic pain-like model in mice
Wang, T., Yin, D., Guo, W. M., Liu, Y., Li, Y., Qu, W., Han, W., Hong, Z., & Huang, Z. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.05.007 · Cited by 29
Song, L., Du, Q., Jiang, X., & Wang, L. (2013) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12118 · Cited by 29
Sleep EEG and amitryptiline treatment in depressed inpatients
Mendlewicz, J., Kempenaers, C., & Maertelaer, V. D. (1991) · Biological Psychiatry · doi:10.1016/0006-3223(91)90014-d · Cited by 28
Uchimura, N., Ogawa, A., Hamamura, M., Hashimoto, T., Nagata, H., & Uchiyama, M. (2011) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.197 · Cited by 27
What's wrong with prescribing hypnotics?
(2004) · Drug and Therapeutics Bulletin · doi:10.1136/dtb.2004.421289 · Cited by 27
Quetiapine for Tamoxifen-Induced Insomnia in Women With Breast Cancer
Pasquini, M., Speca, A., & Biondi, M. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.2.159 · Cited by 23
Khazaie, H., Rezaie, L., Darvishi, F., Najafi, F., & Avis, K. T. (2013) · Neurosciences · doi:10.17712/1658-3183.1994 · Cited by 21
Terán, A., Majadas, S., & y Galán, J. M. T. G. (2008) · Substance Use & Misuse · doi:10.1080/10826080802290240 · Cited by 21
Lelkes, Z., Obál, F., Alföldi, P., Erdös, A., Rubicsek, G., & Benedek, G. (1994) · Pharmacological Research · doi:10.1016/1043-6618(94)80002-2 · Cited by 19
Srisurapanont, M., & Jarusuraisin, N. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb09993.x · Cited by 17
Electrophysiology of Serotonin Receptors
Marek, G. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70077-1 · Cited by 17
Wang‐Weigand, S., Watissée, M., & Roth, T. G. (2011) · Sleep Medicine · doi:10.1016/j.sleep.2011.06.008 · Cited by 16
Sateia, M. J., Sherrill, W., Winter-Rosenberg, C., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6428 · Cited by 16
Pharmacological Characterization of M-II, the Major Human Metabolite of Ramelteon
Nishiyama, K., Nishikawa, H., Kato, K., Miyamoto, M., Tsukamoto, T., & Hirai, K. (2014) · Pharmacology · doi:10.1159/000362459 · Cited by 15
Insomnia treatment by Olanzapine. Is sleep state misperception a psychotic disorder?
Khazaie, H., Rezaie, L., Tahmasian, M., & Schwebel, D. C. (2010) · Neurosciences · doi:10.17712/1658-3183.1778 · Cited by 15
Khazaie, H., Rezaie, L., Darvishi, F., Najafi, F., & Avis, K. T. (2013) · Sleep Medicine · doi:10.1016/j.sleep.2013.11.389 · Cited by 13
Brutcher, R. E., & Nader, M. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3672-5 · Cited by 12
McCall, V. W. (2010) · Medical psychiatry · doi:10.3109/9781420080803.034 · Cited by 4
(1998) · doi:10.1002/(sici)1099-1077(199804)13:3<191::aid-hup972>3.0.co;2-x
Research works printed but not linked: 12
- Cates, 2009, Metabolic consequences of using low-dose quetiapine for insomnia in psychiatric patients, Community Ment Health J, 45, 251, 10.1007/s10597-009-9200-0 · doi:10.1007/s10597-009-9200-0
- Dhillon, 2014, Tasimelteon: first global approval, Drugs, 74, 505, 10.1007/s40265-014-0200-1 · doi:10.1007/s40265-014-0200-1
- Enomoto, 2012, Effects of mirtazapine on sleep disturbance under neuropathic pain-like state, Synapse, 66, 483, 10.1002/syn.21532 · doi:10.1002/syn.21532
- Feeney, 2009, Melatonin agonist tasimelteon improves sleep in primary insomnia characterized by difficulty falling asleep, Sleep, 32, A43
- Laudon, 2012, Tolerability, pharmacokinetic and pharmacodynamic evaluation of multiple ascending doses of Neu-P11 in insomnia patients, Sleep, 35, A221
- Lovenberg, 1999, Cloning and functional expression of the human histamine H3 receptor, Mol Pharmacol, 55, 1101
- Neurim Pharmaceuticals (Tel-Aviv, Israel) (Press release Feb 18 2013) Neurim Pharmaceuticals announces positive Phase 2 clinical trial results of Piromelatine for the treatment of insomnia, Neurim Pharmaceuticals, Tel-Aviv, Israel
- Nilsen, 1992, Single dose pharmacokinetics of trazodone in healthy subjects, Pharmacol Toxicol, 71, 150, 10.1111/j.1600-0773.1992.tb00535.x · doi:10.1111/j.1600-0773.1992.tb00535.x
- Nilsen, 1993, Pharmacokinetics of trazodone during multiple dosing to psychiatric patients, Pharmacol Toxicol, 72, 286, 10.1111/j.1600-0773.1993.tb01651.x · doi:10.1111/j.1600-0773.1993.tb01651.x
- Robinson, 2013, Gabapentin shows promise in treating refractory insomnia in children, J Child Neurol, 28, 1618, 10.1177/0883073812463069 · doi:10.1177/0883073812463069
- Urade, 2003, Sleep regulation in adenosine A2A receptor-deficient mice, Neurology, 61, S94
- Vanda Pharmaceuticals Inc. (Press release, June 26, 2008) Phase III data show Vanda Pharmaceuticals’ tasimelteon (VEC-162) significantly improves sleep in patients with chronic insomnia, Vanda Pharmaceuticals, Rockville, MD
Cited by
Sleep deficiency and chronic pain: potential underlying mechanisms and clinical implications
Haack, M., Simpson, N., Sethna, N., Kaur, S., & Mullington, J. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0439-z · Cited by 641
Perlis, M. L., Posner, D., Riemann, D., Bastien, C. H., Teel, J., & Thase, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00879-0 · Cited by 395
Melatonin’s Impact on Antioxidative and Anti-Inflammatory Reprogramming in Homeostasis and Disease
Chitimus, D. M., Popescu, M. R., Voiculescu, S. E., Panaitescu, A. M., Pavel, B., Zagrean, L., & Zagrean, A.-M. (2020) · Biomolecules · doi:10.3390/biom10091211 · Cited by 354
Jones, B. E. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0444-2 · Cited by 261
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
Metadata
- Authors
- Atkin, T., Comai, S., & Gobbi, G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 70
- Issue
- 2
- Pages
- 197-245
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2788590302
- Cited by
- 391
- References
- 284
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.